S0003699

ABC600mg+3TC300mg tabs/PAC-30


Abacavir Sulfate equivalent to 600mg Abacavir + Lamivudine 300mg film coated tablets, pack of 30
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Abacavir Sulfate equivalent to 600mg Abacavir + Lamivudine 300mg film coated tablets, pack of 30

Technical Specifications:
Each film coated tablet contains Abacavir Sulfate equivalent to 600mg Abacavir plus Lamivudine 300mg.
Tablets should be scored with at least one break line to allow for division of tablets into two parts, each containing the same amount of active ingredients. Pack comes with
Warning Card

Therapeutic class:
Abacavir and Lamivudine are nucleoside reverse transcriptase inhibitors (NRTI).

Standard shelf life:
2 Years (24 Months)

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in adults in combination with at least one other antiretroviral drug. By mouth (oral) PO.

Storage:
Do not store above 30° (86ºF).
Store in tightly closed original container
Keep out of reach and sight of children

Dispensing instructions:
Dispense in original container. Do not repack
Pack comes with Warning Card
Can be taken without regard to food

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items

Related Products